Clinical Trial Update: Azithromycin+Amoxicillin/Clavulanate vs Amoxicillin/Clavulanate in COVID19 Patients With Pneumonia in Non-intensive Unit [Phase 3]

View source ↗

Summary

Phase 3 trial comparing azithromycin plus amoxicillin/clavulanate versus amoxicillin/clavulanate in COVID-19 pneumonia patients not in intensive care.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Pneumonia

Drugs mentioned

• Azithromycin + Amoxicillin/Clavulanate
• amoxicillin-clavulanate (amoxicillin-clavulanate)

Snippet

Sponsor: Nantes University Hospital | Conditions: COVID-19 Pneumonia | Phase 3 | Status: UNKNOWN